<DOC>
	<DOCNO>NCT03001141</DOCNO>
	<brief_summary>This prospective , multicenter , non-randomized registry/observational study . The study enroll 200 patient successful St. Jude Medical ( SJM ) Cardiac Resynchronization Therapy ( CRT ) MP device implant 10 center .</brief_summary>
	<brief_title>Study Protocol/ Registry MultiPointâ„¢ Pacing Brazil</brief_title>
	<detailed_description>Any patient receiving market-approved SJM Quadra Assura MP ( CRT-D ) new model quadripolar device MPP capability meet inclusion criterion none exclusion criterion eligible enrollment study . Patients follow 12 month implant . Data collect device implant ( 30 day successful implant ) , 3 , 6 12 month post-implant unscheduled visit .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient willing able sign Informed Consent Form Any patient receive marketapproved SJM Quadra Assura MP ( CRTD ) new model quadripolar device MPP capability Is likely undergo heart transplantation within 12 month Is less 18 year old Is pregnant plan get pregnant study Is currently take part Clinical Trial active treatment group Life expectancy 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>MultiPoint Pacing</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Resynchronization Therapy</keyword>
	<keyword>Quadripolar pacing</keyword>
</DOC>